FDA Approves Boston Scientific Infinion 16 Percutaneous Lead

The FDA approved Boston Scientific’s Infinion 16 Percutaneous Lead for its Precision Plus Spinal Cord Stimulator system, according to a news release.

Advertisement

This is the first 16-contact percutaneous lead for spinal cord stimulation. Traditionally, leads, which deliver electrical pulses from an implantable pulse generator to the spinal cord, have had a maximum of eight contact points. The extra leads will provide better coverage of the painful area of the spinal cord.

The Infinion 16 Lead will be introduced at the North American Neuromodulation Society meeting that begins today.

Related Articles on Pain Management:
Medical Marijuana Used With Opiates Could Help Patients Reduce Pain
Prevalence of Knee Pain, Symptomatic Knee Osteoarthritis Increasing
BioLineRx Drug Gets Positive Results in Clinical Trial for Neuropathic Pain

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.